Medical Technology for healthcare professionals
Medical Technology
Global market leader in Laser Vision Correction

Why rely on the global market leader in Laser Vision Correction?

Innovative. Supportive. Trusted.

Go with decades of proven experience in laser vision correction

Driven by pioneering innovation, global support and a trustworthy solutions, ZEISS offers one of the most comprehensive Laser Vision Correction portfolios in the industry, enabling tailored laser vision surgery for any eligible patient. But more than just offering options that include PRK, LASIK, PRESBYOND® Laser Blended Vision and SMILE® Lenticule Extraction, ZEISS delivers outstanding clinical application support and comprehensive business consulting that can help surgeons and staff continually succeed. Take advantage of a variety of premier solutions from the global market leader1 in laser vision correction.

Leading the way

Extend your LVC portfolio with the global market leader1

Dr. Robert Morris, Consultant Ophthalmic Surgeon

I was a longstanding myope and was thinking about refractive surgery to deal with my presbyopia and contact lens intolerance, and underwent very successful laser eye surgery with PRESBYOND four years ago.2

Dr. Robert Morris

Consultant Ophthalmic Surgeon, Optegra Eye Hospital, London, UK

See what sets us apart

Patient Material Download Center

Discover ZEISS educational and promotional patient tools for each step of the patient journey.

One connected workflow – from start to finish

The new ZEISS Corneal Refractive Workflow

Streamline your refractive workflow with a digital connected infrastructure and improve efficiency with the right solution for any eligible patient.

Discover the pioneering innovations and global service of the ZEISS LVC portfolio, plus hear directly from surgeons who trust in our technology

Next Step:
  • Step 1
  • Step 2
Step 2

If you want to have more information on data processing at ZEISS please refer to our data privacy notice.

  • 1

    2020 Refractive Surgery Market Report – estimated total revenue.

  • 2

    Statement from November, 2020, Case of the Month, Ophthalmology Times Europe, Vol.16, No.9